_cancer-immunotherapy-101-with-dr-e-john-wherry-preview-1.jpg "Cancer Immunotherapy 101 with Dr. E. John Wherry from immunotherapy in cancer Video Screenshot Preview 1")
Gallery_cancer-immunotherapy-101-with-dr-e-john-wherry-preview-3.jpg "Cancer Immunotherapy 101 with Dr. E. John Wherry from immunotherapy in cancer Video Screenshot Preview 3")
Gallery_cancer-immunotherapy-101-with-dr-e-john-wherry-preview-hqdefault.jpg "Cancer Immunotherapy 101 with Dr. E. John Wherry from immunotherapy in cancer Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 26 minutes 22 seconds
👁 View: 30.2K times
Play Audio:👁 View: 30.2K times
Description:
Cancer Research Institute
Cancer Research Institute
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_prince-william-to-attend-first-royal-engagement-since-kate-middleton39s-cancer-reveal.webp "Prince William is getting ready to go back to work. William understandably took a step back to look after wife Kate Middleton after she announced her cancer diagnosis last month.")
_16-years-cancer-free-thanks-to-immunotherapy-sharon-belvin39s-melanoma-story.webp "Cancer Research Institute")
⏲ 3 minutes 58 seconds 👁 21.3K
_how-is-immunotherapy-for-liver-cancer-changing-the-outlook-for-patients.webp "Cancer Research Institute")
⏲ 30 minutes 59 seconds 👁 2.4K
_the-life-sciences-present-a-golden-opportunity-for-investors-learn-how.webp "The Life Science industry may present a promising investment opportunity. At the forefront of innovation, the industry is poised to benefit from new technologies like artificial intelligence. The pace of new drug development, for instance, is rapidly accelerating; in 2002 there were 17 new drugs approved, and in 2023, there were nearly 60.<br/><br/>Tema ETFs, an active investment adviser, offers three ETFs focused on life sciences – CANC, HRTS and MNTL.<br/><br/>CANC is Tema's Oncology ETF, investing in the prevention of and cure for cancer.<br/><br/>HRTS is Tema's Obesity and Cardiometabolic ETF, addressing the obesity epidemic.<br/><br/>MNTL is Tema's Neuroscience and Mental Health ETF, investing in the future of cognitive health and science.")
_cancer-disappears-in-all-patients-during-immunotherapy-drug-trial.webp "TODAY")
_earl-edwards-will-be-running-his-19th-london-marathon-for-charity.webp "Earl Edwards from Codsall will be running his 19th London Marathon for Breast Cancer Now charity.")
_immunotherapy-treatments-for-non-small-cell-lung-cancer-nsclc.webp "You and Lung Cancer")
_preparing-for-immunotherapy.webp "Fox Chase Cancer Center")
_prince-william-to-attend-first-royal-engagement-since-kate-middleton39s-cancer-reveal.jpg)
_16-years-cancer-free-thanks-to-immunotherapy-sharon-belvin39s-melanoma-story.jpg)
_how-is-immunotherapy-for-liver-cancer-changing-the-outlook-for-patients.jpg)
_the-life-sciences-present-a-golden-opportunity-for-investors-learn-how.jpg)
_cancer-disappears-in-all-patients-during-immunotherapy-drug-trial.jpg)
_earl-edwards-will-be-running-his-19th-london-marathon-for-charity.jpg)
_immunotherapy-treatments-for-non-small-cell-lung-cancer-nsclc.jpg)
_preparing-for-immunotherapy.jpg)
![[+]](/images/menu.gif){kind=small}